5434272025-04-012025-06-305434272025-06-305434272025-04-012025-06-30in-capmkt:OtherExpenses1Member5434272025-04-012025-06-30in-capmkt:ReportableSegments1Member5434272025-04-012025-06-30in-capmkt:ReportableSegments2Member5434272025-04-012025-06-30in-capmkt:ReportableSegments3Member5434272025-04-012025-06-30in-capmkt:ReportableSegments1Member5434272025-04-012025-06-30in-capmkt:ReportableSegments2Member5434272025-04-012025-06-30in-capmkt:ReportableSegments3Member5434272025-04-012025-06-30in-capmkt:ReportableSegments1Member5434272025-06-30in-capmkt:ReportableSegments1Member5434272025-04-012025-06-30in-capmkt:ReportableSegments2Member5434272025-06-30in-capmkt:ReportableSegments2Member5434272025-04-012025-06-30in-capmkt:ReportableSegments3Member5434272025-06-30in-capmkt:ReportableSegments3Member5434272025-04-012025-06-30in-capmkt:ReportableSegments1Member5434272025-06-30in-capmkt:ReportableSegments1Member5434272025-04-012025-06-30in-capmkt:ReportableSegments2Member5434272025-06-30in-capmkt:ReportableSegments2Member5434272025-04-012025-06-30in-capmkt:ReportableSegments3Member5434272025-06-30in-capmkt:ReportableSegments3Member5434272025-04-012025-06-30AuditorDomain1iso4217:INRiso4217:INRxbrli:shares543427MEDPLUSNOTLISTEDINE804L01022Medplus Health Services LimitedMain BoardEquity2025-04-012026-03-312025-08-022025-07-09INRMillionsQuarterlyFirst quarterMulti segment2025-08-0214:00:002025-08-0216:45:00Declaration of unmodified opinion2025-04-012025-06-30UnauditedConsolidated1542634000015019000015576530000191800000105294800006760800002004410000273650000656180000717270000150488700005276600000527660000143920000-3969000010423000004234300000000423430000042343000042358000015000042358000015000023949000023.543.53003.543.53Notes to the Unaudited consolidated financial results: <BR> 1.The above unaudited consolidated financial results of MedPlus Health Services Limited ('The Company') and its subsidiaries (together referred as 'The Group') have been prepared in accordance with Indian Accounting Standards ('Ind AS') prescribed under Section 133 of the Companies Act, 2013 and other accounting principles generally accepted in India and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“listing regulations”) from time to time. These unaudited consolidated financial results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their meetings held on August 02, 2025. These financial results have been subjected to limited review by the Statutory Auditors of the Company and the auditors have expressed and issued an unmodified review report on the same. <BR> 2.During the year ended March 31, 2022, the Company has completed its Initial Public Offering (IPO) of 17,573,342 equity shares of face value of Rs. 2 each for cash at an issue price of Rs. 796 per equity share aggregating to Rs. 13,982.95 million, consisting of Fresh Issue of 7,544,511 equity shares amounting to Rs. 6,000 million and an offer for sale of 10,028,831 equity shares amounting to Rs. 7,982.95 million by the Selling Shareholders. Pursuant to the IPO, the equity shares of the Company were listed on National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) with effect from 23 December 2021. <BR> The utilization of IPO proceeds received by the Company (net of IPO related expense) is summarized below: <BR> (Rs. In Millions) <BR> Objects as per Prospectus Planned utilisation as per Prospectus Utilisation up to <BR> June 30, 2025 Unutilised amount as on June 30, 2025* <BR> i) Investment in Subsidiary - Optival Health Solutions Private Limited towards their working capital requirements 4,671.70 4,671.70 - <BR> ii) General Corporate Purposes 1,117.63 448.53 669.10 <BR> Total 5,789.33 5,120.23 669.10 <BR> *The aforesaid unutilised proceeds of Rs. 669.10 million have been placed as fixed deposits with bank. <BR> 3.The consolidated figures for the quarter ended March 31, 2025 are the balancing figures between audited figures in respect of the full financial year and the published unaudited year to date figures upto the third quarter of said financial year. <BR> 4.The earnings per equity share for the quarters are not annualised. <BR> 5.The above financial results are also available at the Stock Exchange's website i.e. www.bseindia.com, www.nseindia.com and the Company's website www.medplusindia.com. <BR> For and on behalf of the Board of Directors of <BR> MedPlus Health Services Limited <BR> G.Madhukar Reddy <BR> Managing Director and Chief Executive Officer <BR> DIN: 00098097 <BR> Place: Hyderabad <BR> Date: August 02, 2025Other Expenses717270000a. Retail15121190000b. Diagnostics Services302900000c. Others22500001542634000015426340000a. Retail449540000b. Diagnostics Services770000c. Others1070000451380000270000-76550000527660000a. Retail26783080000b. Diagnostics Services1427400000c. Others593000028216410000628453000034500940000a. Retail15669740000b. Diagnostics Services983750000c. Others157000016655060000016655060000UnauditedtrueB S R and Cotrue2026-04-30